Oncotarget

Research Papers:

L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents

Laura Conti, Stefania Lanzardo _, Roberto Ruiu, Marta Cadenazzi, Federica Cavallo, Silvio Aime and Simonetta Geninatti Crich

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:66713-66727. https://doi.org/10.18632/oncotarget.10920

Metrics: PDF 1892 views  |   HTML 1800 views  |   ?  


Abstract

Laura Conti1,*, Stefania Lanzardo1,*, Roberto Ruiu1, Marta Cadenazzi1, Federica Cavallo1, Silvio Aime1, Simonetta Geninatti Crich1

1Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy

*These authors have contributed equally to this work

Correspondence to:

Stefania Lanzardo, email: stefania.lanzardo@unito.it

Simonetta Geninatti Crich, email: simonetta.geninatti@unito.it

Keywords: ferritin, cancer stem cells, theranostic agents, magnetic resonance imaging, mammary tumors

Received: February 23, 2016    Accepted: July 18, 2016    Published: July 29, 2016

ABSTRACT

A growing body of evidence suggests that cancer stem cells (CSC) have the unique biological properties necessary for tumor maintenance and spreading, and function as a reservoir for the relapse and metastatic evolution of the disease by virtue of their resistance to radio- and chemo-therapies. Thus, the efficacy of a therapeutic approach relies on its ability to effectively target and deplete CSC. In this study, we show that CSC-enriched tumorspheres from breast cancer cell lines display an increased L-Ferritin uptake capability compared to their monolayer counterparts as a consequence of the upregulation of the L-Ferritin receptor SCARA5. L-Ferritin internalization was exploited for the simultaneous delivery of Curcumin, a natural therapeutic molecule endowed with antineoplastic action, and the MRI contrast agent Gd-HPDO3A, both entrapped in the L-Ferritin cavity. This theranostic system was able to impair viability and self-renewal of tumorspheres in vitro and to induce the regression of established tumors in mice. In conclusion, here we show that Curcumin-loaded L-Ferritin has a strong therapeutic potential due to the specific targeting of CSC and the improved Curcumin bioavailability, opening up the possibility of its use in a clinical setting.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 10920